News
News
Information
Sysmex’s XR™-Series Automated Hematology Analyzer Receives U.S. FDA 510(k) Clearance
Sysmex Corporation (HQ: Kobe, Japan; President: Kaoru Asano) announces that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its XR-Series Automated Hematology Analyzer.
Sysmex will continue preparations for the early market launch of this product in the United States.
- The purpose of this news is to communicate our business activities to our stakeholders. It may or may not include information about Sysmex's products or their research and development, but this is not intended for promotion, advertising, or medical advice. The information contained in this press release is current as of the date of the announcement but may be subject to change without prior notice.